NASDAQ:AFYA - Afya Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $30.14
  • Forecasted Upside: 29.69 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$23.24
▼ -0.54 (-2.27%)

This chart shows the closing price for AFYA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Afya Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AFYA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AFYA

Analyst Price Target is $30.14
▲ +29.69% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Afya in the last 3 months. The average price target is $30.14, with a high forecast of $34.00 and a low forecast of $26.00. The average price target represents a 29.69% upside from the last price of $23.24.

This chart shows the closing price for AFYA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 investment analysts is to buy stock in Afya.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/1/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/26/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/26/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/25/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/25/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/21/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$32.00 ➝ $28.50High
4/15/2021UBS GroupUpgradeNeutral ➝ BuyHigh
2/4/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$34.00High
10/19/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$32.00High
9/27/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy$23.90 ➝ $30.20High
9/23/2020Credit Suisse GroupReiterated RatingHold$26.00Low
9/15/2020Bank of AmericaReiterated RatingBuy$32.00High
8/19/2020Credit Suisse GroupInitiated CoverageNeutral$26.00Low
5/20/2020Banco SantanderDowngradeHold$21.50Medium
5/20/2020UBS GroupDowngradeBuy ➝ Neutral$31.00 ➝ $21.50High
5/5/2020JPMorgan Chase & Co.Lower Price TargetOverweight$33.00 ➝ $24.50Medium
3/20/2020Itau BBA SecuritiesUpgradeMarket Perform ➝ Outperform$28.00High
3/9/2020JPMorgan Chase & Co.Lower Price TargetOverweight$35.00 ➝ $33.00High
1/23/2020Bank of AmericaInitiated CoverageBuy$35.00Low
1/15/2020UBS GroupBoost Price TargetBuy$29.00 ➝ $31.00High
9/19/2019UBS GroupInitiated CoverageBuy$29.00 ➝ $29.00High
8/13/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$26.00Low
8/13/2019Morgan StanleyInitiated CoverageOverweight ➝ Overweight$29.20Low
8/13/2019Bank of AmericaInitiated CoverageBuy ➝ Buy$29.00 ➝ $29.00Low
8/9/2019JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$34.00Medium
(Data available from 7/25/2016 forward)
Afya logo
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides distance learning residency preparatory courses; and develops and sells digital and printed medical content. As of December 31, 2020, it operated a network of 24 undergraduate and graduate medical school campuses consisted of 19 operating units and five approved units. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Read More

Today's Range

Now: $23.24
Low: $23.11
High: $24.39

50 Day Range

MA: $24.99
Low: $21.58
High: $27.84

52 Week Range

Now: $23.24
Low: $18.48
High: $29.01

Volume

118,182 shs

Average Volume

109,190 shs

Market Capitalization

$2.16 billion

P/E Ratio

38.73

Dividend Yield

N/A

Beta

1.33

Frequently Asked Questions

What sell-side analysts currently cover shares of Afya?

The following equities research analysts have issued stock ratings on Afya in the last year: Bank of America Co., Credit Suisse Group AG, JPMorgan Chase & Co., Morgan Stanley, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for AFYA.

What is the current price target for Afya?

5 Wall Street analysts have set twelve-month price targets for Afya in the last year. Their average twelve-month price target is $30.14, suggesting a possible upside of 29.7%. JPMorgan Chase & Co. has the highest price target set, predicting AFYA will reach $34.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $26.00 for Afya in the next year.
View the latest price targets for AFYA.

What is the current consensus analyst rating for Afya?

Afya currently has 2 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AFYA will outperform the market and that investors should add to their positions of Afya.
View the latest ratings for AFYA.

What other companies compete with Afya?

How do I contact Afya's investor relations team?

Afya's physical mailing address is ALAMEDA OSCAR NIEMEYER NO 119 SALA 504 VILA DA SERRA, NOVA LIMA D5, . The company's listed phone number is 55-31-3515-7550 and its investor relations email address is [email protected] The official website for Afya is www.afya.com.br.